why choose us

First received: May 24, 2023

Clinical Trial: Eculizumab in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) in China

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Paroxysmal Nocturnal Hemoglobinuria

Study Type: INTERVENTIONAL


Official Title: Open-Label, Multicenter Study to Assess the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Eculizumab in Complement Inhibitor Treatment Naïve Adult Participants With Parox

Brief Summary: This is a Phase 3b, single-arm, open-label, multicenter study to evaluate the efficacy, safety, pharmacokinetics (PK), pharmacodynamics (PD), and immunogenicity of eculizumab in adult participants with paraxysmal noturnal hemoglobinuria (PNH) in China.

Read more